AUPO727097A0 - Method of treatment of hepatoma and pharmaceutical compositions for use therein - Google Patents

Method of treatment of hepatoma and pharmaceutical compositions for use therein

Info

Publication number
AUPO727097A0
AUPO727097A0 AUPO7270A AUPO727097A AUPO727097A0 AU PO727097 A0 AUPO727097 A0 AU PO727097A0 AU PO7270 A AUPO7270 A AU PO7270A AU PO727097 A AUPO727097 A AU PO727097A AU PO727097 A0 AUPO727097 A0 AU PO727097A0
Authority
AU
Australia
Prior art keywords
hepatoma
treatment
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO7270A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unisearch Ltd
Original Assignee
Unisearch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unisearch Ltd filed Critical Unisearch Ltd
Priority to AUPO7270A priority Critical patent/AUPO727097A0/en
Publication of AUPO727097A0 publication Critical patent/AUPO727097A0/en
Priority to EP98923934A priority patent/EP1003523A4/en
Priority to AU76316/98A priority patent/AU735676B2/en
Priority to CNB988067609A priority patent/CN1154497C/zh
Priority to PCT/AU1998/000440 priority patent/WO1998056387A1/en
Priority to ZA985028A priority patent/ZA985028B/xx
Priority to KR10-1999-7011663A priority patent/KR100382219B1/ko
Priority to US09/445,688 priority patent/US6486144B1/en
Priority to JP50114299A priority patent/JP2002504100A/ja
Priority to HK01100738.6A priority patent/HK1030144B/xx
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AUPO7270A 1997-06-10 1997-06-10 Method of treatment of hepatoma and pharmaceutical compositions for use therein Abandoned AUPO727097A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AUPO7270A AUPO727097A0 (en) 1997-06-10 1997-06-10 Method of treatment of hepatoma and pharmaceutical compositions for use therein
HK01100738.6A HK1030144B (en) 1997-06-10 1998-06-10 Method for treatment of liver tumours and pharmaceutical compositions for use therein
PCT/AU1998/000440 WO1998056387A1 (en) 1997-06-10 1998-06-10 Method of treatment of liver tumours and pharmaceutical compositions for use therein
AU76316/98A AU735676B2 (en) 1997-06-10 1998-06-10 Method of treatment of liver tumours and pharmaceutical compositions for use therein
CNB988067609A CN1154497C (zh) 1997-06-10 1998-06-10 治疗肝脏肿瘤的方法和其中所用的药学组合物
EP98923934A EP1003523A4 (en) 1997-06-10 1998-06-10 Method of treatment of liver tumours and pharmaceutical compositions for use therein
ZA985028A ZA985028B (en) 1997-06-10 1998-06-10 Method of treating liver tumours and pharmaceutical compositions for use therein
KR10-1999-7011663A KR100382219B1 (ko) 1997-06-10 1998-06-10 간 종양 치료용 조성물
US09/445,688 US6486144B1 (en) 1997-06-10 1998-06-10 Method of treatment of liver tumors and pharmaceutical compositions for use therein
JP50114299A JP2002504100A (ja) 1997-06-10 1998-06-10 肝腫瘍の治療方法およびそれに使用するための医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO7270A AUPO727097A0 (en) 1997-06-10 1997-06-10 Method of treatment of hepatoma and pharmaceutical compositions for use therein

Publications (1)

Publication Number Publication Date
AUPO727097A0 true AUPO727097A0 (en) 1997-07-03

Family

ID=3801562

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO7270A Abandoned AUPO727097A0 (en) 1997-06-10 1997-06-10 Method of treatment of hepatoma and pharmaceutical compositions for use therein

Country Status (8)

Country Link
US (1) US6486144B1 (enExample)
EP (1) EP1003523A4 (enExample)
JP (1) JP2002504100A (enExample)
KR (1) KR100382219B1 (enExample)
CN (1) CN1154497C (enExample)
AU (1) AUPO727097A0 (enExample)
WO (1) WO1998056387A1 (enExample)
ZA (1) ZA985028B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6087350A (en) 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
AU765846B2 (en) * 1998-05-04 2003-10-02 Mrc Holdings Pty Limited Pharmaceutical composition
AUPP332898A0 (en) * 1998-05-04 1998-05-28 Unisearch Limited Pharmaceutical composition
US20030031670A1 (en) * 1999-11-08 2003-02-13 Jack R. Wands Diagnosis and treatment of malignant neoplasms
WO2001034199A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
DE10032587A1 (de) * 2000-07-05 2002-01-17 Bayer Ag 4-Alkoxy-cyclohexan-1-amino-carbonsäureester und Verfahren zu ihrer Herstellung
AU781168B2 (en) 2001-01-26 2005-05-12 Pfizer Products Inc. Method of treating certain cancers using an estrogen agonist/antagonist
US20050038022A1 (en) * 2001-03-26 2005-02-17 Unisearch Limited Method for treatment of cancer and compositions for use therein
JP2004026811A (ja) * 2002-04-30 2004-01-29 Kiyoshi Hashizume ビタミンｄ３誘導体を含有する抗癌作用を増強させるための薬剤
AU2002330482A1 (en) 2002-09-04 2004-03-29 Perseus Proteomics Inc. Method of diagnosing cancer by detecting gpc3
WO2004047673A2 (en) * 2002-11-21 2004-06-10 Novacea, Inc. Treatment of liver disease with active vitamin d compounds
WO2005027922A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. 2-alkylidene-19-nor-vitamin d derivatives for the treatment of hypogonadism or andropause
WO2005027916A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
CA2539361A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen agonist/antagonist
WO2005027918A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a cyclooxgenase-2 inhibitor
WO2005027928A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. 2-alkylidene-19-nor-vit amin d derivatives for the treatment of hypocalcemic tetany or hyproparathyroidism
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
JP4248544B2 (ja) * 2005-12-19 2009-04-02 株式会社椿本チエイン 伝動装置用可動ガイド
AU2010282731C1 (en) * 2009-08-14 2016-04-21 Berg Llc Vitamin D3 and analogs thereof for treating alopecia
EP2988752A4 (en) 2013-04-24 2017-01-18 Salk Institute for Biological Studies Vitamin d receptor/smad genomic circuit gates fibrotic response
CN105451818A (zh) * 2013-06-05 2016-03-30 萨克生物研究学院 治疗涉及cxcl12活性的疾病的维生素d受体激动剂
JP2016124818A (ja) * 2014-12-26 2016-07-11 日本化薬株式会社 転移性肝癌治療薬及び転移性肝癌の治療方法
WO2016167977A1 (en) 2015-04-14 2016-10-20 Mayo Foundation For Medical Education And Research Methods and materials for delivering agents to liver tissue
WO2019023149A1 (en) 2017-07-24 2019-01-31 Salk Institute For Biological Studies USE OF BROMODOMAIN-CONTAINING PROTEIN-9 ANTAGONISTS IN ASSOCIATION WITH VITAMIN D RECEPTOR AGONISTS IN THE TREATMENT OF DIABETES
CN116059364B (zh) * 2021-11-04 2025-07-11 上海健康医学院 Dhcr7下调剂在减弱酒精诱导的肝脏肿瘤中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0296800B1 (en) * 1987-06-23 1991-10-16 Yamanouchi Pharmaceutical Co. Ltd. Vitamin d3 derivatives
US4927815A (en) * 1988-04-29 1990-05-22 Wisconsin Alumni Research Foundation Compounds effective in inducing cell differentiation and process for preparing same
US5798345A (en) 1990-09-21 1998-08-25 Bone Care International, Inc. Method of inhibiting the hyperproliferation of malignant cells
DK0707566T3 (da) * 1993-07-09 2000-09-04 Theramex Hidtil ukendte strukturelle analoger til vitamin D
US5856189A (en) * 1997-01-07 1999-01-05 The Regents Of The University Of Michigan Cell culture model for drug bioavailability

Also Published As

Publication number Publication date
ZA985028B (en) 1999-01-25
US6486144B1 (en) 2002-11-26
CN1261800A (zh) 2000-08-02
KR100382219B1 (ko) 2003-04-26
HK1030144A1 (en) 2001-04-27
JP2002504100A (ja) 2002-02-05
EP1003523A4 (en) 2001-08-22
EP1003523A1 (en) 2000-05-31
WO1998056387A1 (en) 1998-12-17
KR20010013651A (ko) 2001-02-26
CN1154497C (zh) 2004-06-23

Similar Documents

Publication Publication Date Title
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
HUP0000808A3 (en) Pharmaceutical composition of fenofibrate and method for preparing same
PL330814A1 (en) Compounds for and methods of delivering pharmaceutical preparations and their application
HUP9702035A3 (en) Inhibitors of leukocita-adhesion- and vla-4-antagonists and pharmaceutical compositions containing them
HUP9702036A3 (en) Inhibitors of leucocita-adhesion and wla-4-antagonists and pharmaceutical compositions containing them
HUP9902105A3 (en) Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
HUP9702034A3 (en) Inhibitors of leukocita-adhesion and vla-4-antagonists and pharmaceutical compositions containing them
HUP0300836A3 (en) Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
GB9812056D0 (en) Pharmaceutical composition for treatment of ibd and rbd
LT99141A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
GB9710800D0 (en) Pharmaceutical composition and method of preparing it
AU9016898A (en) Methods and compositions for treatment of restenosis
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
IL132516A0 (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
IL121329A (en) Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU7836798A (en) Compositions for delivery of biological agents and methods for the preparation thereof
AU6720698A (en) Pharmaceutical compositions containing colostrum and the use of colostrum for the treatment of hair loss
AU6786798A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU8580598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
AU6786698A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
HUP9900251A3 (en) Pharmaceutical compositions containing hedgehog proteins and use of former compositions
AUPO732597A0 (en) Pharmaceutical agent and method of treatment